Osteoneurogen Inc.

Binex Co., Ltd.

Ik Hwan Kim

Han Soo Kim

Byung Soo Youn

Ho Sup Yoon

Kyung Seop Ahn

Baik Lin Seong

Sang Ki Kim

Moon Kee Maeng

Min Ju Ham

Hyeong Deok Choi

Se Young Chong

Jun Hwan Kim

The present invention relates to an anti-inflammatory composition, and more particularly to an anti-inflammatory composition containing, as an active ingredient, a compound represented by Formula 1 or a salt thereof, wherein the anti-inflammatory composition may inhibit inflammatory response even at an early stage by inhibiting the interaction between CD14 and LPS and blocking the expression of CD14 and the expression of TNF&#x3b1; and IL-1&#x3b2;, which are the key factors in inflammatory response, and may also regulate the expression of important factors, such as CCL2 (MCP-1), CCL7 (MCP-3), CXCL2, CHOP and NOX1, which are involved in inflammatory response.

Anti-inflammatory composition

A compound represented by the following Formula 1 or a pharmaceutically acceptable salt thereof: 

Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis

A pharmaceutical composition comprising decursin and its uses as a nephrotoxicity inhibitor, an antineoplastic agent, an antidiabetic agent, and as a cancer-cell differentiation induction agent are disclosed.

Pharmaceutical composition containing decursin

Growing community of inventors

Seoul, South Korea

Ik Hwan Kim